V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002453 | 10001611 | null | null | Palliative (P) | 2018-06-17 | 2018-06-17 | Cisplatin + Pemetrexed | null | N | 10435155 | CISPLATIN + PEMETREXED |
| 10002454 | 10001612 | 1.56 | 56.3 | Disease modification (D) | 2016-12-30 | 2017-01-02 | Hydroxycarbamide | 02 | N | 10435268 | HYDROXYCARBAMIDE |
| 10002455 | 10006198 | 1.61 | 93.2 | Palliative (P) | 2018-01-01 | 2018-01-28 | Carboplatin + Vinorelbine Oral | 02 | N | 10435307 | CARBOPLATIN + VINORELBINE |
| 10002456 | 10001613 | 1.65 | 77.2 | Curative (C) | 2015-08-21 | 2015-08-25 | CVP R | N | N | 10435336 | CVP R |
| 10002457 | 10001613 | 1.56 | 71.4 | Palliative (P) | 2014-07-27 | 2014-07-28 | Cisplatin + Pemetrexed | 2 | null | 10435336 | CISPLATIN + PEMETREXED |
| 10002458 | 10007982 | 1.77 | 60.3 | Palliative (P) | 2017-12-21 | 2018-01-04 | Rituximab (Maintenance) | N | N | 10435392 | RITUXIMAB |
| 10002459 | 10001614 | 1.76 | 72.2 | Disease modification (D) | 2016-03-16 | 2016-03-29 | R GCVP | N | N | 10435441 | CVP R |
| 10002460 | 10001614 | 1.65 | null | Palliative (P) | 2017-09-02 | 2017-09-02 | Cisplatin + Pemetrexed | 02 | N | 10435441 | CISPLATIN + PEMETREXED |
| 10002461 | 10001615 | 1.6 | 48.65 | Palliative (P) | 2017-02-03 | 2017-02-09 | CVP R | 2 | N | 10435520 | CVP R |
| 10002462 | 10001615 | null | 78.8 | Adjuvant (A) | 2016-08-18 | 2016-08-18 | CISPLATIN + VINORELBINE | N | null | 10435520 | CISPLATIN + VINORELBINE |
| 10002463 | 10001616 | 1.72 | 0 | Disease modification (D) | 2018-08-27 | 2018-08-28 | Hydroxycarbamide | N | null | 10435546 | HYDROXYCARBAMIDE |
| 10002464 | 10001617 | 0.72 | 102.2 | Palliative (P) | 2016-07-07 | 2016-08-11 | Gemcitabine weekly | N | N | 10435553 | GEMCITABINE |
| 10002465 | 10001618 | 1.81 | 83 | Disease modification (D) | 2017-12-20 | 2017-12-31 | CVP R | N | N | 10435562 | CVP R |
| 10002466 | 10001619 | 1.73 | 75.1 | Palliative (P) | 2017-01-20 | 2017-02-16 | Enzalutamide | N | N | 10435569 | ENZALUTAMIDE |
| 10002467 | 10001619 | 1.74 | 88.1 | Palliative (P) | 2018-12-28 | 2019-01-11 | EOX | 2 | N | 10435569 | EOX |
| 10002468 | 10001620 | 1.8 | 111.35 | Curative (C) | 2017-12-12 | 2018-01-12 | ECX | 02 | N | 10435635 | ECX |
| 10002469 | 10001620 | 0 | null | Palliative (P) | 2018-02-13 | 2018-02-13 | Trial Unspecified | Y | N | 10435635 | TRIAL |
| 10002470 | 10001621 | 1.69 | 64.8 | Disease modification (D) | 2016-09-09 | 2016-09-13 | Hydroxycarbamide | 2 | N | 10435666 | HYDROXYCARBAMIDE |
| 10002471 | 10001621 | null | 72.5 | Palliative (P) | 2016-10-20 | 2016-10-20 | Trial Unspecified | 01 | N | 10435666 | TRIAL |
| 10002472 | 10001621 | 1.52 | 0 | Disease modification (D) | 2018-10-29 | 2018-10-30 | Rituximab | N | N | 10435666 | RITUXIMAB |
| 10002473 | 10001622 | 1.53 | null | Curative (C) | 2017-01-25 | 2017-01-26 | CVP R | N | N | 10435707 | CVP R |
| 10002474 | 10001623 | 1.65 | 58.9 | Palliative (P) | 2014-08-05 | 2014-09-09 | Cisplatin + Pemetrexed | N | null | 10435719 | CISPLATIN + PEMETREXED |
| 10002475 | 10001624 | null | 85.7 | Curative (C) | 2015-06-13 | 2015-06-28 | ECX | N | N | 10435748 | ECX |
| 10002476 | 10001624 | 1.73 | 71.9 | Disease modification (D) | 2017-09-22 | 2017-10-03 | CVP R | 2 | N | 10435748 | CVP R |
| 10002477 | 10001625 | 1.68 | 73.4 | Curative (C) | 2019-04-17 | 2019-04-21 | Trial Unspecified | 01 | N | 10435975 | TRIAL |
| 10002478 | 10001626 | 1.62 | 65.3 | Adjuvant (A) | 2016-12-13 | 2017-01-01 | CARBOPLATIN + VINORELBINE | N | N | 10435986 | CARBOPLATIN + VINORELBINE |
| 10002479 | 10001626 | 1.76 | 69.9 | null | 2018-01-23 | 2018-01-28 | Cisplatin + Pemetrexed | 2 | N | 10435986 | CISPLATIN + PEMETREXED |
| 10002480 | 10001627 | 1.69 | 0 | Curative (C) | 2018-02-01 | 2018-02-14 | CVP R | N | null | 10436023 | CVP R |
| 10002481 | 10001628 | 1.54 | 55.4 | Palliative (P) | 2017-04-02 | 2017-04-02 | Cisplatin + Pemetrexed | null | N | 10436033 | CISPLATIN + PEMETREXED |
| 10002482 | 10001629 | null | null | Adjuvant (A) | 2017-02-23 | 2017-03-05 | EOX | 02 | null | 10436065 | EOX |
| 10002483 | 10001629 | 1.66 | 65.6 | null | 2018-03-17 | 2018-03-23 | Enzalutamide | N | N | 10436065 | ENZALUTAMIDE |
| 10002484 | 10001630 | 1.68 | 69.3 | Palliative (P) | 2016-01-17 | 2016-01-21 | Enzalutamide | 2 | N | 10436089 | ENZALUTAMIDE |
| 10002485 | 10001631 | 1.7 | 77 | Palliative (P) | 2019-01-31 | 2019-02-06 | PEMBROLIZUMAB | N | N | 10436117 | PEMBROLIZUMAB |
| 10002486 | 10001632 | 1.68 | 0 | Disease modification (D) | 2016-01-03 | 2016-01-03 | PEMBROLIZUMAB | 02 | N | 10436203 | PEMBROLIZUMAB |
| 10002487 | 10001633 | 0 | 0 | Palliative (P) | 2015-10-08 | 2015-10-15 | PEMBROLIZUMAB | 02 | N | 10436220 | PEMBROLIZUMAB |
| 10002488 | 10001633 | 1.75 | null | Neo-adjuvant (N) | null | 2014-02-13 | ECX | N | N | 10436220 | ECX |
| 10002489 | 10001633 | null | 100.6 | Palliative (P) | 2018-05-02 | 2018-05-08 | Rituximab | N | N | 10436220 | RITUXIMAB |
| 10002490 | 10001634 | 1.8 | 76 | Adjuvant (A) | 2018-11-17 | 2018-12-04 | Carboplatin + Vinorelbine Oral | N | Y | 10436367 | CARBOPLATIN + VINORELBINE |
| 10002491 | 10001635 | null | 48.65 | Curative (C) | 2017-01-05 | 2017-01-08 | CVP R | N | N | 10436383 | CVP R |
| 10002492 | 10001636 | 1.88 | 89.9 | Adjuvant (A) | 2015-06-19 | 2015-06-30 | Carboplatin + Vinorelbine IV &PO D8 | N | null | 10436386 | CARBOPLATIN + VINORELBINE |
| 10002493 | 10001636 | 0 | 74 | Neo-adjuvant (N) | 2015-05-30 | 2015-06-18 | Carboplatin + Vinorelbine Oral | 02 | N | 10436386 | CARBOPLATIN + VINORELBINE |
| 10002494 | 10001637 | 1.82 | null | Palliative (P) | 2018-11-09 | 2018-11-17 | Enzalutamide | N | N | 10436526 | ENZALUTAMIDE |
| 10002495 | 10001638 | 1.53 | 55.4 | Palliative (P) | 2017-07-02 | 2017-07-03 | Trial Unspecified | 1 | N | 10436529 | TRIAL |
| 10002496 | 10001638 | 1.82 | 75.7 | Not known (9) | 2018-02-13 | 2018-02-14 | Carboplatin + Vinorelbine Oral | N | N | 10436529 | CARBOPLATIN + VINORELBINE |
| 10002497 | 10001638 | null | 85 | Neo-adjuvant (N) | 2016-11-28 | 2016-12-05 | ECX | 2 | N | 10436529 | ECX |
| 10002498 | 10001639 | 1.8 | 85 | Palliative (P) | 2017-03-17 | 2017-03-17 | GO2 TRIAL | Y | N | 10436619 | TRIAL |
| 10002499 | 10001640 | 0 | 76 | Disease modification (D) | 2013-12-18 | 2013-12-18 | Hydroxycarbamide | N | N | 10436655 | HYDROXYCARBAMIDE |
| 10002500 | 10001641 | 2 | 55.4 | Palliative (P) | 2018-06-30 | 2018-07-15 | EOX | N | N | 10436662 | EOX |
| 10002501 | 10006211 | 1.73 | 75.4 | Palliative (P) | 2015-04-12 | 2015-04-12 | ECX | N | N | 10436691 | ECX |
| 10002502 | 10001642 | 0 | 60.4 | Palliative (P) | 2017-05-11 | 2017-05-20 | PEMBROLIZUMAB | N | N | 10436729 | PEMBROLIZUMAB |